FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3049404477> ?p ?o ?g. }

• W3049404477 endingPage "104907" @default.
• W3049404477 startingPage "104907" @default.
• W3049404477 abstract "Despite the availability of a highly effective yellow fever virus (YFV) vaccine, outbreaks of yellow fever frequently occur in Africa and South America with significant mortality, highlighting the pressing need for antiviral drugs to manage future outbreaks. To support the discovery and development of antiviral drugs against YFV, we characterized a panel of rabbit polyclonal antibodies against the three YFV structural proteins and five non-structural proteins and demonstrated these antibody reagents in conjunction with viral RNA metabolic labeling, double-stranded RNA staining and membrane floatation assays as powerful tools for investigating YFV polyprotein processing, replication complex formation, viral RNA synthesis and high throughput discovery of antiviral drugs. Specifically, the proteolytic processing of the viral polyprotein can be analyzed by Western blot assays. The predominant nuclear localization of NS5 protein as well as the relationship between intracellular viral non-structural protein distribution and foci of YFV RNA replication can be revealed by immunofluorescence staining and membrane flotation assays. Using an antibody against YFV NS4B protein as an example, in-cell western and high-content imaging assays have been developed for high throughput discovery of antiviral agents. A synergistic antiviral effect of an YFV NS4B-targeting antiviral agent BDAA and a NS5 RNA-dependent RNA polymerase inhibitor (Sofosbuvir) was also demonstrated with the high-content imaging assay. Apparently, the antibody-based assays established herein not only facilitate the discovery and development of antiviral agents against YFV, but also provide valuable tools to dissect the molecular mechanism by which the antiviral agents inhibit YFV replication." @default.
• W3049404477 created "2020-08-21" @default.
• W3049404477 creator A5019683467 @default.
• W3049404477 creator A5021541475 @default.
• W3049404477 creator A5021720199 @default.
• W3049404477 creator A5023737081 @default.
• W3049404477 creator A5026548119 @default.
• W3049404477 creator A5031849145 @default.
• W3049404477 creator A5055919945 @default.
• W3049404477 creator A5076597546 @default.
• W3049404477 creator A5090605099 @default.
• W3049404477 date "2020-10-01" @default.
• W3049404477 modified "2023-10-12" @default.
• W3049404477 title "Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus" @default.
• W3049404477 cites W1483762054 @default.
• W3049404477 cites W1966243747 @default.
• W3049404477 cites W1967404435 @default.
• W3049404477 cites W1971576099 @default.
• W3049404477 cites W1988313572 @default.
• W3049404477 cites W1991001144 @default.
• W3049404477 cites W1999464123 @default.
• W3049404477 cites W2002587235 @default.
• W3049404477 cites W2002610747 @default.
• W3049404477 cites W2006347591 @default.
• W3049404477 cites W2013519130 @default.
• W3049404477 cites W2024970900 @default.
• W3049404477 cites W2027598863 @default.
• W3049404477 cites W2052214918 @default.
• W3049404477 cites W2096009548 @default.
• W3049404477 cites W2098687402 @default.
• W3049404477 cites W2101575257 @default.
• W3049404477 cites W2136817553 @default.
• W3049404477 cites W2139993960 @default.
• W3049404477 cites W2144902263 @default.
• W3049404477 cites W2150368001 @default.
• W3049404477 cites W2163478597 @default.
• W3049404477 cites W2166561873 @default.
• W3049404477 cites W2171173465 @default.
• W3049404477 cites W2171178051 @default.
• W3049404477 cites W2206025144 @default.
• W3049404477 cites W2491102694 @default.
• W3049404477 cites W2499448993 @default.
• W3049404477 cites W2522300837 @default.
• W3049404477 cites W2761906648 @default.
• W3049404477 cites W2770832678 @default.
• W3049404477 cites W2775210943 @default.
• W3049404477 cites W2806516470 @default.
• W3049404477 cites W2808733288 @default.
• W3049404477 cites W2901211290 @default.
• W3049404477 cites W2945412802 @default.
• W3049404477 cites W2950382369 @default.
• W3049404477 cites W4240905451 @default.
• W3049404477 cites W646785491 @default.
• W3049404477 doi "https://doi.org/10.1016/j.antiviral.2020.104907" @default.
• W3049404477 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7426275" @default.
• W3049404477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32798604" @default.
• W3049404477 hasPublicationYear "2020" @default.
• W3049404477 type Work @default.
• W3049404477 sameAs 3049404477 @default.
• W3049404477 citedByCount "2" @default.
• W3049404477 countsByYear W30494044772022 @default.
• W3049404477 crossrefType "journal-article" @default.
• W3049404477 hasAuthorship W3049404477A5019683467 @default.
• W3049404477 hasAuthorship W3049404477A5021541475 @default.
• W3049404477 hasAuthorship W3049404477A5021720199 @default.
• W3049404477 hasAuthorship W3049404477A5023737081 @default.
• W3049404477 hasAuthorship W3049404477A5026548119 @default.
• W3049404477 hasAuthorship W3049404477A5031849145 @default.
• W3049404477 hasAuthorship W3049404477A5055919945 @default.
• W3049404477 hasAuthorship W3049404477A5076597546 @default.
• W3049404477 hasAuthorship W3049404477A5090605099 @default.
• W3049404477 hasBestOaLocation W30494044771 @default.
• W3049404477 hasConcept C104317684 @default.
• W3049404477 hasConcept C140704245 @default.
• W3049404477 hasConcept C159047783 @default.
• W3049404477 hasConcept C159654299 @default.
• W3049404477 hasConcept C203014093 @default.
• W3049404477 hasConcept C2522874641 @default.
• W3049404477 hasConcept C2776415932 @default.
• W3049404477 hasConcept C2780568436 @default.
• W3049404477 hasConcept C2780879997 @default.
• W3049404477 hasConcept C55493867 @default.
• W3049404477 hasConcept C67705224 @default.
• W3049404477 hasConcept C86803240 @default.
• W3049404477 hasConcept C956191 @default.
• W3049404477 hasConceptScore W3049404477C104317684 @default.
• W3049404477 hasConceptScore W3049404477C140704245 @default.
• W3049404477 hasConceptScore W3049404477C159047783 @default.
• W3049404477 hasConceptScore W3049404477C159654299 @default.
• W3049404477 hasConceptScore W3049404477C203014093 @default.
• W3049404477 hasConceptScore W3049404477C2522874641 @default.
• W3049404477 hasConceptScore W3049404477C2776415932 @default.
• W3049404477 hasConceptScore W3049404477C2780568436 @default.
• W3049404477 hasConceptScore W3049404477C2780879997 @default.
• W3049404477 hasConceptScore W3049404477C55493867 @default.
• W3049404477 hasConceptScore W3049404477C67705224 @default.
• W3049404477 hasConceptScore W3049404477C86803240 @default.
• W3049404477 hasConceptScore W3049404477C956191 @default.

• next